Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Korro Bio, Inc. - Common Stock
(NQ:
KRRO
)
7.990
-0.020 (-0.25%)
Streaming Delayed Price
Updated: 12:15 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Korro Bio, Inc. - Common Stock
< Previous
1
2
Next >
The Great Rotation: Small-Caps Seize the Spotlight as Mega-Cap Fatigue Sets In
December 22, 2025
As 2025 draws to a close, the financial landscape has undergone a seismic shift that few predicted at the start of the year. For the first time in over half a decade, the dominant narrative of "Big...
Via
MarketMinute
Topics
Economy
The Great Rotation: Small-Caps Break Out as Russell 2000 Hits Record Highs in Late 2025
December 18, 2025
NEW YORK — In a dramatic shift that has recalibrated the pulse of Wall Street, the Russell 2000 index has finally staged its long-awaited breakout, signaling a definitive end to the years-long...
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Korro Bio Stock Crashes Over 75% After-Hours On Drug Failure, Downgrades And Layoffs — Yet Retail Flags ‘Buy-The-Fear’ Setup
↗
November 12, 2025
Via
Stocktwits
Topics
Workforce
On Monday, there are stocks with unusual volume. Let's take a look.
↗
November 17, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
November 13, 2025
Via
Benzinga
Keep an eye on the top gainers and losers in Thursday's session.
↗
November 13, 2025
Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Korro Bio Early Trial Results Fall Short; Stock Hits New Low
↗
November 13, 2025
Korro Bio shares drop after KRRO-110 trial in AATD misses protein goals; company cuts 34% of staff and shifts focus to liver-targeted programs.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
November 13, 2025
Via
Benzinga
Dow Dips Over 400 Points; JD.com Posts Upbeat Q3 Results
↗
November 13, 2025
Via
Benzinga
Topics
Stocks
Which stocks are gapping on Thursday?
↗
November 13, 2025
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
Nasdaq Down Over 150 Points; Disney Shares Fall After Q4 Results
↗
November 13, 2025
Via
Benzinga
Korro Bio Plummets To A Record Low On A Big Setback In RNA-Editing
↗
November 13, 2025
Korro Bio stock plummeted Thursday after its RNA-editing drug failed in patients with a rare lung and liver disease.
Via
Investor's Business Daily
Stay updated with the stocks that are on the move in today's pre-market session.
↗
November 13, 2025
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 13, 2025
Via
Benzinga
Why Cisco Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
↗
November 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 20, 2025
Via
Benzinga
3 Biotech Stocks Showing Strength With Big Spikes In Momentum Scores
↗
September 12, 2025
A handful of biotech stocks are showing renewed strength, with big spikes in their Benzinga Edge Ranking's Momentum scores.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 27, 2025
Via
Benzinga
Uber To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
↗
May 08, 2025
Via
Benzinga
This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
April 16, 2025
Via
Benzinga
This TechnipFMC Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
November 18, 2024
Via
Benzinga
Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
↗
October 21, 2024
Korro Bio is lagging Wave Life Sciences. But an analyst says it could ultimately be the leader.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 16, 2024
Via
Benzinga
United Airlines Posts Upbeat Earnings, Joins Morgan Stanley, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday
↗
October 16, 2024
Via
Benzinga
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
↗
September 19, 2024
This strategic play will take time to pay off, but it could keep growth going.
Via
The Motley Fool
Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications
↗
September 18, 2024
Wednesday, Canada-based NanoVation Therapeutics announced a multi-year partnership with Novo Nordisk A/S (NYSE:NVO) to advance the ...
Via
Benzinga
Gold Edges Lower; US Homebuilder Sentiment Rises For September
↗
September 17, 2024
Via
Benzinga
Crude Oil Gains Over 1%; US Business Inventories Increase In July
↗
September 17, 2024
Via
Benzinga
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
↗
August 14, 2024
William Blair initiates coverage on Korro Bio highlighting its innovative RNA editing platform, ADAR-based OPERA. The analyst rates the stock Outperform, noting its potential in treating alpha-1...
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
